L R Duska

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology
    L R Duska
    Vincent Gynecology Service, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston 02114, USA
    Obstet Gynecol 91:278-82. 1998
  2. ncbi request reprint Fertility options for patients with stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues
    L R Duska
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston 02114, USA
    Obstet Gynecol 92:656-8. 1998
  3. ncbi request reprint Endometrial cancer in women 40 years old or younger
    L R Duska
    Vincent Gynecology Service, Division of Gynecologic Oncology, Boston, Massachusetts 02114, USA
    Gynecol Oncol 83:388-93. 2001
  4. ncbi request reprint BAG-1 expression in normal and neoplastic endometrium
    T Moriyama
    Vincent Center for Reproductive Biology, Massachusetts General Hospital Boston, Boston, MA 02114, USA
    Gynecol Oncol 94:289-95. 2004
  5. ncbi request reprint Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel
    A P Vaidya
    Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Int J Gynecol Cancer 16:267-72. 2006
  6. ncbi request reprint Clinically significant venous thromboembolism after gynecologic surgery
    J O Schorge
    Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Reprod Med 44:669-73. 1999

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology
    L R Duska
    Vincent Gynecology Service, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston 02114, USA
    Obstet Gynecol 91:278-82. 1998
    ..To determine the incidence of and identify risk factors for clinically significant diagnoses associated with the diagnosis on Papanicolaou test of atypical glandular cells of undetermined significance...
  2. ncbi request reprint Fertility options for patients with stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues
    L R Duska
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston 02114, USA
    Obstet Gynecol 92:656-8. 1998
    ..Traditional therapy for stage IA2 and IB lesions, radical hysterectomy, negates future fertility potential. Assisted reproductive technology might offer these women fertility options...
  3. ncbi request reprint Endometrial cancer in women 40 years old or younger
    L R Duska
    Vincent Gynecology Service, Division of Gynecologic Oncology, Boston, Massachusetts 02114, USA
    Gynecol Oncol 83:388-93. 2001
    ..The aim of this study was to characterize endometrial cancer in women 40 years of age and younger, with special attention toward body-mass index (BMI)...
  4. ncbi request reprint BAG-1 expression in normal and neoplastic endometrium
    T Moriyama
    Vincent Center for Reproductive Biology, Massachusetts General Hospital Boston, Boston, MA 02114, USA
    Gynecol Oncol 94:289-95. 2004
    ..High levels of BAG-1 have been implicated as a prognostic indicator in breast cancer. Whether this observation can be generalized to endometrial cancer remains unknown...
  5. ncbi request reprint Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel
    A P Vaidya
    Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Int J Gynecol Cancer 16:267-72. 2006
    ..The results of our study show a high response rate to paclitaxel/carboplatin outpatient chemotherapy in a group of patients historically believed to have chemoresistant disease. Further prospective study of this regimen is planned...
  6. ncbi request reprint Clinically significant venous thromboembolism after gynecologic surgery
    J O Schorge
    Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Reprod Med 44:669-73. 1999
    ..To review the incidence and outcome of clinically significant venous thromboembolism (VTE) following gynecologic surgery in a population receiving provider-specified prophylaxis...